24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Basic InformationLookupsLatest News
AHA News: Never Heard of Sepsis? It's Common, Dangerous and a Threat to Your HeartModerna Says Its COVID Vaccine Works Well in Children Aged 6 to 11COVID Vaccination Does Not Raise Odds of Miscarriage: StudyVaccinated People Less Likely to Die of Any Cause in Months After Shots: CDCRecovering COVID Patients Often Face Long-Term 'Brain Fog'COVID Pandemic May Have Driven a Flu Strain Into ExtinctionThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollAnother Study Finds Pfizer, Moderna Shots Effective Against COVID VariantsLyme Disease Often Spotted at Later Stage in Black PatientsFDA Panel Supports Moderna Booster Shot for Older Adults, People at High RiskIs a Really Bad Flu Season on the Way?Climate Change Could Bring Rising Obesity RatesKids Can Carry High, Infectious Levels of COVID CoronavirusMore Than Half of COVID-19 Survivors Will Get 'Long COVID'One-Third of Americans With Arthritis Get No ExerciseDeath Threats, Trolling Common for Scientists Who Speak to Media About COVIDAHA News: The Differences and Similarities Between the Flu and COVID-19
Questions and AnswersLinks
Related Topics


FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans

HealthDay News
by By Robin Foster and Cara Murez HealthDay Reporters
Updated: Sep 23rd 2021

new article illustration

THURSDAY, Sept. 23, 2021 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday approved Pfizer booster shots for people over 65 and for those at high risk of severe COVID-19.

Under the emergency use authorization, the booster shots should be given at least six months after a person is fully vaccinated.

Wednesday's move is likely the beginning of a staggered campaign to deliver booster shots to all Americans, starting with the most vulnerable.

"Today's action demonstrates that science and the currently available data continue to guide the FDA's decision-making for COVID-19 vaccines during this pandemic," Acting FDA Commissioner Dr. Janet Woodcock said in an agency news release.

"After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA [emergency use authorization] for the Pfizer-BioNTech COVID-19 vaccine to allow for a booster dose in certain populations, such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others," Woodcock added.

"This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day," Woodcock said. "As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed."

Still, exactly who qualifies as high risk because of health or work reasons isn't crystal clear yet. That is expected to be clarified by an advisory panel to the U.S. Centers for Disease Control and Prevention, which is in the midst of a two-day meeting on the issue, The New York Times reported.

The final recommendation from the CDC advisory panel, expected Thursday, will likely be quickly endorsed by CDC Director Rochelle Walensky, the Washington Post reported, and the shots could be available as soon as this week at pharmacies and some doctor's offices.

The challenge for the CDC panel "is to make a recommendation that is appropriate from the public health perspective and easy to communicate," William Schaffner, an infectious disease professor at Vanderbilt University School of Medicine, in Nashville, Tenn., and a liaison member of the panel, told the Post.

During a meeting last week, the FDA's vaccine advisory committee said health care workers should be eligible. A senior FDA regulator has said teachers should be eligible, and some have suggested that inmates and staff at prisons should be included because of their unique risks.

Those at higher risk of COVID-19 complications because of health reasons may include as many as 60% of Americans, who have obesity and other chronic medical conditions, the Times reported.

About 22 million Americans received their second doses about six months ago, and half of them are now eligible by age, the Times reported.

Limited data from Israel and the United States shows there were fewer side effects after a third dose of mRNA vaccines compared with the second dose, according to a presentation made to the CDC panel on Wednesday, the Post reported.

However, some of those who are 65 or older had one of the two other vaccines, made by Moderna and Johnson & Johnson. They will need to wait to learn whether their vaccines will also have boosters, with decisions expected in the coming weeks, the Times reported.

Meanwhile, limiting action to the Pfizer vaccine poses challenges for health workers, issues that surfaced repeatedly during the CDC vaccine advisory committee meeting on Wednesday, the Post reported. For example, nursing home residents and employees have received both Pfizer and Moderna shots.

"In North Dakota, the vast majority [of long-term-care facilities] had a mixture of people that needed both Moderna and Pfizer," Molly Howell, director of North Dakota's immunization program and a liaison member to the CDC panel, told the Post. "I don't know that it's realistic to keep going back with different brands."

Even if the CDC panel takes a different stance than the FDA did on the need for boosters, health care providers are now authorized to offer these third shots to eligible people who received the Pfizer vaccine, the Times reported.

The authorization follows weeks of debate inside the FDA, where some regulators challenged the need for boosters for the general population. Public health experts and state officials have criticized what they called confusing public messages. Among those messages was one from the White House last month, in which President Joe Biden announced boosters for all American adults eight months after their second doses, pending regulatory approval.

The United States now joins Germany, France, Israel and Britain in offering boosters that some say should go instead to poorer countries that still need first and second doses, the Times reported.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCES: The New York Times; Washington Post; U.S. Food and Drug Administration, news release, Sept. 22, 2021